10/08/2026
Forty-two years ago, a landmark policy changed the future of rare disease drug development.
Today, the next challenge isn't creating more breakthroughs, it's making sure those breakthroughs reach every patient who needs them.
Our latest blog explores how the legacy of the Orphan Drug Act extends beyond legislation and why patient organizations, cross-border collaboration, accessible clinical trials, and stronger care networks are essential to turning scientific progress into real-world impact.
At IndoUSrare, we believe innovation is only meaningful when it improves lives.
📖 Read the full blog and discover how we're helping bridge the gap between policy, research, and patient care.
🔗 https://www.indousrare.org/blog/rare-disease-roadmap-insights-from-42-years-of-the-orphan-drug-act/
🌐 Learn more about IndoUSrare and our work: https://www.indousrare.org/